Loading…
Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer
To evaluate the treatment results in early stage non-small cell lung cancer patients who have undergone fiducial-less CyberKnife radiosurgery (CKRS). From June 2011 to November 2013, 58 patients underwent CKRS at Asan Medical Center for stage I lung cancer. After excluding 14 patients, we retrospect...
Saved in:
Published in: | Radiation oncology journal 2015, 33(2), , pp.89-97 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3 |
container_end_page | 97 |
container_issue | 2 |
container_start_page | 89 |
container_title | Radiation oncology journal |
container_volume | 33 |
creator | Jung, In-Hye Song, Si Yeol Jung, Jinhong Cho, Byungchul Kwak, Jungwon Je, Hyoung Uk Choi, Wonsik Jung, Nuri Hyun Kim, Su Ssan Choi, Eun Kyung |
description | To evaluate the treatment results in early stage non-small cell lung cancer patients who have undergone fiducial-less CyberKnife radiosurgery (CKRS).
From June 2011 to November 2013, 58 patients underwent CKRS at Asan Medical Center for stage I lung cancer. After excluding 14 patients, we retrospectively reviewed the records of the remaining 44 patients. All analyses were performed using SPSS ver. 21.
The median age at diagnosis was 75 years. Most patients had inoperable primary lung cancer with a poor pulmonary function test with comorbidity or old age. The clinical stage was IA in 30 patients (68.2%), IB in 14 (31.8%). The mean tumor size was 2.6 cm (range, 1.2 to 4.8 cm), and the tumor was smaller than 2 cm in 12 patients (27.3%). The radiation dose given was 48-60 Gy in 3-4 fractions. In a median follow-up of 23.1 months, local recurrence occurred in three patients (2-year local recurrence-free survival rate, 90.4%) and distant metastasis occurred in 13 patients. All patients tolerated the radiosurgery well, only two patients developing grade 3 dyspnea. The most common complications were radiation-induced fibrosis and pneumonitis. Eight patients died due to cancer progression.
The results showed that fiducial-less CKRS shows comparable local tumor control and survival rates to those of LINAC-based SABR or CKRS with a fiducial marker. Thus, fiducial-less CKRS using Xsight lung tracking system can be effectively and safely performed for patients with medically inoperable stage I non-small cell lung cancer without any risk of procedure-related complication. |
doi_str_mv | 10.3857/roj.2015.33.2.89 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_667966</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1695180145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3</originalsourceid><addsrcrecordid>eNpVUU1r3DAQNaWlCUnuORUde7Grb0uXQlj6sTRQCOlZ0cqjrRJZ2kp2YP99vdk0becwMzDvvZnhNc0lwR1Tov9Q8n1HMREdYx3tlH7VnFLKeMuIkK-fe6IxPmkuar3HS0gspMRvmxMqiehlr06bu1UMKTgbUZ4nl0dA2SMfhtkFG9sItaLVfgPlWwoeULFDyHUuWyh75HNBdbJbQGuUcmrraGNEDpYU57RFziYH5bx5422scPFcz5ofnz_drr6219-_rFdX163jWkytVXIzcO_toIYeQAunhw11kuNDJrTX2oPVwCijVNCecqDEecdZL5SiwM6a90fdVLx5cMFkG57qNpuHYq5ubtdGyl5LuUA_HqG7eTPC4CBNxUazK2G0Zf9E_H-Sws9F5tFwrhln7O-uXcm_ZqiTGUM9PG4T5LkaIrUgChMuFig-Ql3JtRbwL2sINgcbzWKjOdhoGDPUKL1Q3v173gvhj2nsN4BEmnY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1695180145</pqid></control><display><type>article</type><title>Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Jung, In-Hye ; Song, Si Yeol ; Jung, Jinhong ; Cho, Byungchul ; Kwak, Jungwon ; Je, Hyoung Uk ; Choi, Wonsik ; Jung, Nuri Hyun ; Kim, Su Ssan ; Choi, Eun Kyung</creator><creatorcontrib>Jung, In-Hye ; Song, Si Yeol ; Jung, Jinhong ; Cho, Byungchul ; Kwak, Jungwon ; Je, Hyoung Uk ; Choi, Wonsik ; Jung, Nuri Hyun ; Kim, Su Ssan ; Choi, Eun Kyung</creatorcontrib><description>To evaluate the treatment results in early stage non-small cell lung cancer patients who have undergone fiducial-less CyberKnife radiosurgery (CKRS).
From June 2011 to November 2013, 58 patients underwent CKRS at Asan Medical Center for stage I lung cancer. After excluding 14 patients, we retrospectively reviewed the records of the remaining 44 patients. All analyses were performed using SPSS ver. 21.
The median age at diagnosis was 75 years. Most patients had inoperable primary lung cancer with a poor pulmonary function test with comorbidity or old age. The clinical stage was IA in 30 patients (68.2%), IB in 14 (31.8%). The mean tumor size was 2.6 cm (range, 1.2 to 4.8 cm), and the tumor was smaller than 2 cm in 12 patients (27.3%). The radiation dose given was 48-60 Gy in 3-4 fractions. In a median follow-up of 23.1 months, local recurrence occurred in three patients (2-year local recurrence-free survival rate, 90.4%) and distant metastasis occurred in 13 patients. All patients tolerated the radiosurgery well, only two patients developing grade 3 dyspnea. The most common complications were radiation-induced fibrosis and pneumonitis. Eight patients died due to cancer progression.
The results showed that fiducial-less CKRS shows comparable local tumor control and survival rates to those of LINAC-based SABR or CKRS with a fiducial marker. Thus, fiducial-less CKRS using Xsight lung tracking system can be effectively and safely performed for patients with medically inoperable stage I non-small cell lung cancer without any risk of procedure-related complication.</description><identifier>ISSN: 2234-1900</identifier><identifier>EISSN: 2234-3156</identifier><identifier>EISSN: 2234-3164</identifier><identifier>DOI: 10.3857/roj.2015.33.2.89</identifier><identifier>PMID: 26157678</identifier><language>eng</language><publisher>Korea (South): The Korean Society for Radiation Oncology</publisher><subject>Original ; 방사선과학</subject><ispartof>Radiation oncology journal , 2015, 33(2), , pp.89-97</ispartof><rights>Copyright © 2015. The Korean Society for Radiation Oncology 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3</citedby><cites>FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493433/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493433/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26157678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002003598$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, In-Hye</creatorcontrib><creatorcontrib>Song, Si Yeol</creatorcontrib><creatorcontrib>Jung, Jinhong</creatorcontrib><creatorcontrib>Cho, Byungchul</creatorcontrib><creatorcontrib>Kwak, Jungwon</creatorcontrib><creatorcontrib>Je, Hyoung Uk</creatorcontrib><creatorcontrib>Choi, Wonsik</creatorcontrib><creatorcontrib>Jung, Nuri Hyun</creatorcontrib><creatorcontrib>Kim, Su Ssan</creatorcontrib><creatorcontrib>Choi, Eun Kyung</creatorcontrib><title>Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer</title><title>Radiation oncology journal</title><addtitle>Radiat Oncol J</addtitle><description>To evaluate the treatment results in early stage non-small cell lung cancer patients who have undergone fiducial-less CyberKnife radiosurgery (CKRS).
From June 2011 to November 2013, 58 patients underwent CKRS at Asan Medical Center for stage I lung cancer. After excluding 14 patients, we retrospectively reviewed the records of the remaining 44 patients. All analyses were performed using SPSS ver. 21.
The median age at diagnosis was 75 years. Most patients had inoperable primary lung cancer with a poor pulmonary function test with comorbidity or old age. The clinical stage was IA in 30 patients (68.2%), IB in 14 (31.8%). The mean tumor size was 2.6 cm (range, 1.2 to 4.8 cm), and the tumor was smaller than 2 cm in 12 patients (27.3%). The radiation dose given was 48-60 Gy in 3-4 fractions. In a median follow-up of 23.1 months, local recurrence occurred in three patients (2-year local recurrence-free survival rate, 90.4%) and distant metastasis occurred in 13 patients. All patients tolerated the radiosurgery well, only two patients developing grade 3 dyspnea. The most common complications were radiation-induced fibrosis and pneumonitis. Eight patients died due to cancer progression.
The results showed that fiducial-less CKRS shows comparable local tumor control and survival rates to those of LINAC-based SABR or CKRS with a fiducial marker. Thus, fiducial-less CKRS using Xsight lung tracking system can be effectively and safely performed for patients with medically inoperable stage I non-small cell lung cancer without any risk of procedure-related complication.</description><subject>Original</subject><subject>방사선과학</subject><issn>2234-1900</issn><issn>2234-3156</issn><issn>2234-3164</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUU1r3DAQNaWlCUnuORUde7Grb0uXQlj6sTRQCOlZ0cqjrRJZ2kp2YP99vdk0becwMzDvvZnhNc0lwR1Tov9Q8n1HMREdYx3tlH7VnFLKeMuIkK-fe6IxPmkuar3HS0gspMRvmxMqiehlr06bu1UMKTgbUZ4nl0dA2SMfhtkFG9sItaLVfgPlWwoeULFDyHUuWyh75HNBdbJbQGuUcmrraGNEDpYU57RFziYH5bx5422scPFcz5ofnz_drr6219-_rFdX163jWkytVXIzcO_toIYeQAunhw11kuNDJrTX2oPVwCijVNCecqDEecdZL5SiwM6a90fdVLx5cMFkG57qNpuHYq5ubtdGyl5LuUA_HqG7eTPC4CBNxUazK2G0Zf9E_H-Sws9F5tFwrhln7O-uXcm_ZqiTGUM9PG4T5LkaIrUgChMuFig-Ql3JtRbwL2sINgcbzWKjOdhoGDPUKL1Q3v173gvhj2nsN4BEmnY</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Jung, In-Hye</creator><creator>Song, Si Yeol</creator><creator>Jung, Jinhong</creator><creator>Cho, Byungchul</creator><creator>Kwak, Jungwon</creator><creator>Je, Hyoung Uk</creator><creator>Choi, Wonsik</creator><creator>Jung, Nuri Hyun</creator><creator>Kim, Su Ssan</creator><creator>Choi, Eun Kyung</creator><general>The Korean Society for Radiation Oncology</general><general>대한방사선종양학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>20150601</creationdate><title>Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer</title><author>Jung, In-Hye ; Song, Si Yeol ; Jung, Jinhong ; Cho, Byungchul ; Kwak, Jungwon ; Je, Hyoung Uk ; Choi, Wonsik ; Jung, Nuri Hyun ; Kim, Su Ssan ; Choi, Eun Kyung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Original</topic><topic>방사선과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, In-Hye</creatorcontrib><creatorcontrib>Song, Si Yeol</creatorcontrib><creatorcontrib>Jung, Jinhong</creatorcontrib><creatorcontrib>Cho, Byungchul</creatorcontrib><creatorcontrib>Kwak, Jungwon</creatorcontrib><creatorcontrib>Je, Hyoung Uk</creatorcontrib><creatorcontrib>Choi, Wonsik</creatorcontrib><creatorcontrib>Jung, Nuri Hyun</creatorcontrib><creatorcontrib>Kim, Su Ssan</creatorcontrib><creatorcontrib>Choi, Eun Kyung</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Radiation oncology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, In-Hye</au><au>Song, Si Yeol</au><au>Jung, Jinhong</au><au>Cho, Byungchul</au><au>Kwak, Jungwon</au><au>Je, Hyoung Uk</au><au>Choi, Wonsik</au><au>Jung, Nuri Hyun</au><au>Kim, Su Ssan</au><au>Choi, Eun Kyung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer</atitle><jtitle>Radiation oncology journal</jtitle><addtitle>Radiat Oncol J</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>33</volume><issue>2</issue><spage>89</spage><epage>97</epage><pages>89-97</pages><issn>2234-1900</issn><eissn>2234-3156</eissn><eissn>2234-3164</eissn><abstract>To evaluate the treatment results in early stage non-small cell lung cancer patients who have undergone fiducial-less CyberKnife radiosurgery (CKRS).
From June 2011 to November 2013, 58 patients underwent CKRS at Asan Medical Center for stage I lung cancer. After excluding 14 patients, we retrospectively reviewed the records of the remaining 44 patients. All analyses were performed using SPSS ver. 21.
The median age at diagnosis was 75 years. Most patients had inoperable primary lung cancer with a poor pulmonary function test with comorbidity or old age. The clinical stage was IA in 30 patients (68.2%), IB in 14 (31.8%). The mean tumor size was 2.6 cm (range, 1.2 to 4.8 cm), and the tumor was smaller than 2 cm in 12 patients (27.3%). The radiation dose given was 48-60 Gy in 3-4 fractions. In a median follow-up of 23.1 months, local recurrence occurred in three patients (2-year local recurrence-free survival rate, 90.4%) and distant metastasis occurred in 13 patients. All patients tolerated the radiosurgery well, only two patients developing grade 3 dyspnea. The most common complications were radiation-induced fibrosis and pneumonitis. Eight patients died due to cancer progression.
The results showed that fiducial-less CKRS shows comparable local tumor control and survival rates to those of LINAC-based SABR or CKRS with a fiducial marker. Thus, fiducial-less CKRS using Xsight lung tracking system can be effectively and safely performed for patients with medically inoperable stage I non-small cell lung cancer without any risk of procedure-related complication.</abstract><cop>Korea (South)</cop><pub>The Korean Society for Radiation Oncology</pub><pmid>26157678</pmid><doi>10.3857/roj.2015.33.2.89</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2234-1900 |
ispartof | Radiation oncology journal , 2015, 33(2), , pp.89-97 |
issn | 2234-1900 2234-3156 2234-3164 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_667966 |
source | PubMed Central; EZB Electronic Journals Library |
subjects | Original 방사선과학 |
title | Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A33%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20outcome%20of%20fiducial-less%20CyberKnife%20radiosurgery%20for%20stage%20I%20non-small%20cell%20lung%20cancer&rft.jtitle=Radiation%20oncology%20journal&rft.au=Jung,%20In-Hye&rft.date=2015-06-01&rft.volume=33&rft.issue=2&rft.spage=89&rft.epage=97&rft.pages=89-97&rft.issn=2234-1900&rft.eissn=2234-3156&rft_id=info:doi/10.3857/roj.2015.33.2.89&rft_dat=%3Cproquest_nrf_k%3E1695180145%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c495t-a86bd4ffad8d7ee95c9db2c640b2c612799fea9e3232252724e21cfc4375882e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1695180145&rft_id=info:pmid/26157678&rfr_iscdi=true |